Age1

Age1 Age1 is a longevity-focused venture capital fund investing in companies that target biological aging mechanisms. The thesis is straightforward: aging is the primary risk factor for most major diseases, and addressing it directly is both scientifically sound and commercially viable. The firm makes early-stage investments in longevity therapeutics and supports founders developing novel approaches to extending healthy lifespan. Age1 is part of the emerging longevity investment category that ha